- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05281250
Evaluation of Physical Exercise to Prevent Functional Deterioration During Hospitalization (EFFAPRO) (EFFAPRO)
March 4, 2022 updated by: Ana Ruiz-Casado, Puerta de Hierro University Hospital
Evaluation of Physical Exercise as a Protective Factor for the Loss of Functional Capacity in Patients With Metastatic Tumors During Hospitalization. Pilot Study (EFFAPRO)
This is a randomized study that will measure the possible benefit of supervised training during the hospitalization of patients with stage IV neoplasms in active treatment.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The trial is not going to be runned
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Madrid
-
Majadahonda, Madrid, Spain, 28222
- Hospital Universitario Puerta de Hierro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with stage IV neoplasms.
- Active treatment: chemotherapy, hormone therapy, immunotherapy or targeted therapies.
- Hospitalization at Medical Oncology Departmentof the Hospital Puerta de Hierro.
- Reason for hospitalization is expected to be solved in less than two weeks.
Exclusion Criteria:
- Patients who do not wish to participate.
- Cognitive impairment.
- Hospitalization due to progression of oncological disease.
- Acute coronary syndrome or bone fracture in limbs during the previous three months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supervised physical exercise
Supervised exercise (aerobic + strength + flexibility) depending on the functional capacity of each patient, during hospitalization
|
A supervised exercise is randomized.
Although this intervention is not standard in our setting, it is a recommended practice, since it is known that rehabilitation strategies in hospitalized patients have different benefits.
|
No Intervention: Control
Patients will receive recommendations about exercising during hospitalization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional capacity
Time Frame: Through study completion (average 10 days)
|
Functional Independence Measure (FIM)
|
Through study completion (average 10 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Strength
Time Frame: Through study completion (average 10 days).
|
Dynamometry
|
Through study completion (average 10 days).
|
Cardiorespiratory condition
Time Frame: Through study completion (average 10 days)
|
Six minute test .
|
Through study completion (average 10 days)
|
Daily physical activity
Time Frame: Through study completion (average 10 days)
|
Accelerometry during the hospitalization.
|
Through study completion (average 10 days)
|
Fatigue-FACIT
Time Frame: Through study completion (average 10 days)
|
FACIT Fatigue Scale
|
Through study completion (average 10 days)
|
Fatigue-PERFORM
Time Frame: Through study completion (average 10 days)
|
PERFORM Fatigue questionnaire (12-60) Higher, better (less fatigue)
|
Through study completion (average 10 days)
|
Life quality: Q30 questionnaire
Time Frame: Through study completion (average 10 days)
|
QLQ30 questionnaire (quality of life).
0-100 (HIGHER, better)
|
Through study completion (average 10 days)
|
Anxiety and depression
Time Frame: Through study completion (average 10 days)
|
HADS questionnaire (anxiety and depression).
0-42 (less better)
|
Through study completion (average 10 days)
|
Length of hospital stay
Time Frame: Through study completion (average 10 days).
|
Number of days the patient is hospitalized.
|
Through study completion (average 10 days).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ana Ruiz Casado, Puerta de Hierro University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 28, 2018
Primary Completion (Actual)
August 28, 2018
Study Completion (Actual)
August 28, 2018
Study Registration Dates
First Submitted
August 27, 2018
First Submitted That Met QC Criteria
March 4, 2022
First Posted (Actual)
March 16, 2022
Study Record Updates
Last Update Posted (Actual)
March 16, 2022
Last Update Submitted That Met QC Criteria
March 4, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- PH-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Patients
-
Memorial Sloan Kettering Cancer CenterColumbia University; NYU Langone Health; Roswell Park Cancer Institute; Jacobi... and other collaboratorsRecruiting
-
KTO Karatay UniversityCompleted
-
University Hospital, Basel, SwitzerlandCompletedCancer PatientsSwitzerland
-
Petros DinasCompleted
-
Jiandong ZhangRecruiting
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Canon Medical Systems, USACompleted
-
Milton S. Hershey Medical CenterCompleted
-
Thomas SeufferleinUnknown
-
Hospices Civils de LyonCompleted
Clinical Trials on Supervised physical exercise
-
Bioaraba Health Research InstituteRecruitingStress, Psychological | AnxietySpain
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknownSystemic Lupus ErythematosusBrazil
-
Universidad Politecnica de MadridUnknown
-
University of Illinois at Urbana-ChampaignCompletedQuality of Life | Physical Activity | Cognitive Impairment | Cancer of the ProstateUnited States
-
UNICANCERCAMI: Sport & CancerActive, not recruitingHome Based Standardised Adapted Physical Activity Programme | Patients Taking Oral Targeted Therapy for Metastatic CancerFrance
-
Technical University of MadridUnknown
-
Kuopio University HospitalUniversity of Eastern FinlandCompleted
-
Universidad Politecnica de MadridUnknown
-
Aarhus University Hospital SkejbyInstitute for Clinical and Experimental MedicineCompletedHeart Failure | Coronary Heart Disease | Ischemic Heart DiseasesDenmark
-
Istanbul UniversityCompletedRotator Cuff InjuriesTurkey